Why Lexeo Therapeutics LXEO looks attractive at current levels Parabolic 20260511 ECCD Eagle sparse quarterly earnings disclosures leave investors awaiting upcoming operational and strategic guidance updates Haleon plc HLN Stock Execution Price Underperforming 20260420 USAC USA reports Q4 2025 earnings per share miss notches minor share gain amid muted investor reaction